A new breakthrough could prevent the key side effects of popular weight loss drugs such as Ozempic. The drugs also improve ...

Exercise boosts blood flow, reduces stress and more. It also prompts muscles to secrete messengers that guard against ...

There are a series of molecules in clinical trials, 16 in phase III, with different mechanisms of action. Some are small; ...

Alzheimer's disease is the most common cause of dementia in the elderly and is characterized by abnormal deposits of amyloid-beta and tau proteins in the brain. This disease has a ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

QuantalX Neuroscience Ltd. is proud to announce that its Delphi-MD (Direct Electrophysiological Imaging Device), an ...

Nexalin Technology (NXL) released a letter to shareholders from its CEO Mark White: “I am pleased to provide an update on Nexalin ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this debilitating disease.

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...